wwtmm, disease stage and patient ECOG status are different things.
SUNRISE is stage IIIB and IV. Same as preceding Phase II trial.
SUNRISE recruits patients with ECOG 0 or 1. In preceding Phase II trial, ECOG 2 were also recruited. This is the difference here. Bavituximab does not seem to help those sicker patients as much as it helps healthier ones.